Leucine aminopeptidase is elevated in obstruction of
**Core Concept**
Leucine aminopeptidase (LAP) is an enzyme found in the bile duct epithelium. Its elevation in serum is indicative of bile duct obstruction, which leads to the release of this enzyme into the bloodstream.
**Why the Correct Answer is Right**
In the case of bile duct obstruction, the increased pressure and cellular damage lead to the release of LAP into the circulation. This enzyme is then detected in elevated levels in the blood, serving as a diagnostic marker for bile duct obstruction. The elevation of LAP is due to the damage to the bile duct epithelium, which normally contains this enzyme. This damage can be caused by conditions such as bile duct stones, strictures, or tumors.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the elevation of LAP. While liver disease can cause elevations in liver enzymes, LAP is specifically associated with bile duct obstruction, not liver disease.
**Option B:** This option is incorrect because LAP elevation is not typically associated with renal disease. Renal disease may cause elevations in other enzymes such as creatinine or urea, but not typically LAP.
**Option C:** This option is incorrect because LAP elevation is not typically associated with pancreatic disease. While pancreatic disease can cause elevations in pancreatic enzymes such as amylase or lipase, LAP is specifically associated with bile duct obstruction.
**Clinical Pearl / High-Yield Fact**
Bile duct obstruction can be caused by a variety of conditions, including bile duct stones, strictures, or tumors. The elevation of LAP in serum is a diagnostic marker for bile duct obstruction, and its presence should prompt further investigation to identify the underlying cause.
**Correct Answer: C. Pancreas**